Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Health and Quality of Life Outcomes
Published in: Health and Quality of Life Outcomes 1/2014

Open Access 01-12-2014 | Research

The impact of preoperative patient characteristics on health states after total hip replacement and related satisfaction thresholds: a cohort study

Authors: Matthias Vogl, Rainer Wilkesmann, Christian Lausmann, Matthias Hunger, Werner Plötz

Published in: Health and Quality of Life Outcomes | Issue 1/2014

Login to get access

Abstract

Background

The aim of the study was to analyze the effect of preoperative patient characteristics on health outcomes 6 months after total hip replacement (THR), to support patient's decision making in daily practice with predicted health states and satisfaction thresholds. By giving incremental effects for different patient subgroups, we support comparative effectiveness research (CER) on osteoarthritis interventions.

Methods

In 2012, 321 patients participated in health state evaluation before and 6 months after THR. Health-related quality of life (HRQoL) was measured with the EQ-5D questionnaire. Hip-specific pain, function, and mobility were measured with the WOMAC in a prospective observation of a cohort. The predictive capability of preoperative patient characteristics – classified according to socio-demographic factors, medical factors, and health state variables – for changes in health outcomes is tested by correlation analysis and multivariate linear regressions. Related satisfaction thresholds were calculated with the patient acceptable symptom state (PASS) concept.

Results

The mean WOMAC and EQ-5D scores before operation were 52 and 60 respectively (0 worst, 100 best). At the 6-month follow-up, scores improved by 35 and 19 units. On average, patients reported satisfaction with the operation if postoperative (change) WOMAC scores were higher than 85 (32) and postoperative (change) EQ-5D scores were higher than 79 (14).

Conclusions

Changes in WOMAC and EQ-5D scores can mainly be explained by preoperative scores. The lower the preoperative WOMAC or EQ-5D scores, the higher the change in the scores. Very good or very poor preoperative scores lower the probability of patient satisfaction with THR. Shared decision making using a personalized risk assessment approach provides predicted health states and satisfaction thresholds.
Appendix
Available only for authorised users
Literature
1.
Laupacis A, Bourne R, Rorabeck C, Feeny D, Wong C, Tugwell P, Leslie K, Bullas R: The effect of elective total hip replacement on health-related quality of life. J Bone Joint Surg Am 1993, 75: 1619–1626.PubMed
2.
Ethgen O, Bruyere O, Richy F, Dardennes C, Reginster JY: Health-related quality of life in total hip and total knee arthroplasty. A qualitative and systematic review of the literature. J Bone Joint Surg Am 2004, 86-A: 963–974.PubMed
3.
Biring GS, Masri BA, Greidanus NV, Duncan CP, Garbuz DS: Predictors of quality of life outcomes after revision total hip replacement. J Bone Joint Surg (Br) 2007, 89: 1446–1451. 10.1302/0301-620X.89B11.19617CrossRef
4.
Learmonth ID, Young C, Rorabeck C: The operation of the century: total hip replacement. Lancet 2007, 370: 1508–1519. 10.1016/S0140-6736(07)60457-7CrossRefPubMed
5.
Kurtz S, Ong K, Lau E, Mowat F, Halpern M: Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am 2007, 89: 780–785. 10.2106/JBJS.F.00222CrossRefPubMed
6.
7.
Hawker GA, Badley EM, Borkhoff CM, Croxford R, Davis AM, Dunn S, Gignac MA, Jaglal SB, Kreder HJ, Sale JE: Which patients are most likely to benefit from total joint arthroplasty? Arthritis Rheum 2013, 65: 1243–1252. 10.1002/art.37901CrossRefPubMed
8.
Stratford PW, Kennedy DM: Performance measures were necessary to obtain a complete picture of osteoarthritic patients. J Clin Epidemiol 2006, 59: 160–167. 10.1016/j.jclinepi.2005.07.012CrossRefPubMed
9.
Ostendorf M, van Stel HF, Buskens E, Schrijvers AJ, Marting LN, Verbout AJ, Dhert WJ: Patient-reported outcome in total hip replacement. A comparison of five instruments of health status. J Bone Joint Surg (Br) 2004, 86: 801–808. 10.1302/0301-620X.86B6.14950CrossRef
10.
Veenhof C, Bijlsma JW, van den Ende CH, van Dijk GM, Pisters MF, Dekker J: Psychometric evaluation of osteoarthritis questionnaires: a systematic review of the literature. Arthritis Rheum 2006, 55: 480–492. 10.1002/art.22001CrossRefPubMed
11.
Alambuya RN, Ali S, Apostolidis K, Beinfeld MT, Bijwe SR, Bravo P, Brocklehurst W, Davis R, Dhir A, Dodd CR, Durand MA, Eaton S, Faber M, Fisler CM, Ford PA, Westrick MG, Nikovska DG, Hendy MA, Johnson C, Johnstone R, Laitner S, Lam LS, Lee DM, Lynch HF, Mankeekar PC, Mbaabu LM, McCay L, Monti M, Moulton BW, Muthambi TC, et al.: Salzburg statement on shared decision making. BMJ 2011, 342: d1745. 10.1136/bmj.d1745CrossRef
12.
13.
Sorenson C, Gusmano MK, Oliver A: The politics of comparative effectiveness research: lessons from recent history. J Health Polit Policy Law 2013, [Epub ahead of print].
14.
Tubach F, Ravaud P, Baron G, Falissard B, Logeart I, Bellamy N, Bombardier C, Felson D, Hochberg M, van der Heijde D, Dougados M: Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state. Ann Rheum Dis 2005, 64: 34–37. 10.1136/ard.2004.023028PubMedCentralCrossRefPubMed
15.
Escobar A, Gonzalez M, Quintana JM, Vrotsou K, Bilbao A, Herrera-Espineira C, Garcia-Perez L, Aizpuru F, Sarasqueta C: Patient acceptable symptom state and OMERACT-OARSI set of responder criteria in joint replacement. Identification of cut-off values. Osteoarthritis Cartilage 2012, 20: 87–92. 10.1016/j.joca.2011.11.007CrossRefPubMed
16.
Arden NK, Kiran A, Judge A, Biant LC, Javaid MK, Murray DW, Carr AJ, Cooper C, Field RE: What is a good patient reported outcome after total hip replacement? Osteoarthritis Cartilage 2011, 19: 155–162. 10.1016/j.joca.2010.10.004CrossRefPubMed
17.
18.
Chesworth BM, Mahomed NN, Bourne RB, Davis AM: Willingness to go through surgery again validated the WOMAC clinically important difference from THR/TKR surgery. J Clin Epidemiol 2008, 61: 907–918. 10.1016/j.jclinepi.2007.10.014CrossRefPubMed
19.
Singh J, Sloan JA, Johanson NA: Challenges with health-related quality of life assessment in arthroplasty patients: problems and solutions. J Am Acad Orthop Surg 2010, 18: 72–82.PubMedCentralPubMed
20.
Kvien TK, Heiberg T, Hagen KB: Minimal clinically important improvement/difference (MCII/MCID) and patient acceptable symptom state (PASS): what do these concepts mean? Ann Rheum Dis 2007, 66 Suppl 3: iii40–41.PubMed
21.
22.
23.
Leidl R, Reitmeir P: A value set for the EQ-5D based on experienced health states: development and testing for the German population. Pharmacoeconomics 2011, 29: 521–534. 10.2165/11538380-000000000-00000CrossRefPubMed
24.
Dolan P: Modelling valuations for health states: the effect of duration. Health Policy 1996, 38: 189–203. 10.1016/0168-8510(96)00853-6CrossRefPubMed
25.
Whitehead SJ, Ali S: Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull 2010, 96: 5–21. 10.1093/bmb/ldq033CrossRefPubMed
26.
Barton GR, Sach TH, Avery AJ, Doherty M, Jenkinson C, Muir KR: Comparing the performance of the EQ-5D and SF-6D when measuring the benefits of alleviating knee pain. Cost Eff Resour Alloc 2009, 7: 12. 10.1186/1478-7547-7-12PubMedCentralCrossRefPubMed
27.
Stucki G, Meier D, Stucki S, Michel BA, Tyndall AG, Dick W, Theiler R: [Evaluation of a German version of WOMAC (Western Ontario and McMaster Universities) Arthrosis Index]. Z Rheumatol 1996, 55: 40–49.PubMed
28.
Roos EM, Klassbo M, Lohmander LS: WOMAC osteoarthritis index. Reliability, validity, and responsiveness in patients with arthroscopically assessed osteoarthritis. Western Ontario and MacMaster Universities. Scand J Rheumatol 1999, 28: 210–215. 10.1080/03009749950155562CrossRefPubMed
29.
Van Breukelen GJ: ANCOVA versus change from baseline: more power in randomized studies, more bias in nonrandomized studies [corrected]. J Clin Epidemiol 2006, 59: 920–925. 10.1016/j.jclinepi.2006.02.007CrossRefPubMed
30.
Judge A, Arden NK, Kiran A, Price A, Javaid MK, Beard D, Murray D, Field RE: Interpretation of patient-reported outcomes for hip and knee replacement surgery: identification of thresholds associated with satisfaction with surgery. J Bone Joint Surg (Br) 2012, 94: 412–418. 10.1302/0301-620X.94B3.27425CrossRef
31.
Davis AM, Agnidis Z, Badley E, Kiss A, Waddell JP, Gross AE: Predictors of functional outcome two years following revision hip arthroplasty. J Bone Joint Surg Am 2006, 88: 685–691. 10.2106/JBJS.E.00150CrossRefPubMed
32.
Fortin PR, Clarke AE, Joseph L, Liang MH, Tanzer M, Ferland D, Phillips C, Partridge AJ, Bélisle P, Fossel AH, Mahomed N, Sledge CB, Katz JN: Outcomes of total hip and knee replacement: preoperative functional status predicts outcomes at six months after surgery. Arthritis Rheum 1999, 42: 1722–1728. 10.1002/1529-0131(199908)42:8<1722::AID-ANR22>3.0.CO;2-RCrossRefPubMed
33.
Nilsdotter AK, Petersson IF, Roos EM, Lohmander LS: Predictors of patient relevant outcome after total hip replacement for osteoarthritis: a prospective study. Ann Rheum Dis 2003, 62: 923–930. 10.1136/ard.62.10.923PubMedCentralCrossRefPubMed
34.
Roder C, Staub LP, Eggli S, Dietrich D, Busato A, Muller U: Influence of preoperative functional status on outcome after total hip arthroplasty. J Bone Joint Surg Am 2007, 89: 11–17. 10.2106/JBJS.E.00012CrossRefPubMed
35.
Anakwe RE, Jenkins PJ, Moran M: Predicting dissatisfaction after total hip arthroplasty: a study of 850 patients. J Arthroplasty 2011, 26: 209–213. 10.1016/j.arth.2010.03.013CrossRefPubMed
36.
Kvamme MK, Kristiansen IS, Lie E, Kvien TK: Identification of cutpoints for acceptable health status and important improvement in patient-reported outcomes, in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol 2010, 37: 26–31. 10.3899/jrheum.090449CrossRefPubMed
37.
Schafer T, Pritzkuleit R, Jeszenszky C, Malzahn J, Maier W, Gunther KP, Niethard F: Trends and geographical variation of primary hip and knee joint replacement in Germany. Osteoarthritis Cartilage 2013, 21: 279–288. 10.1016/j.joca.2012.11.006CrossRefPubMed
38.
Gutacker N, Bojke C, Daidone S, Devlin N, Street A: Hospital variation in patient-reported outcomes at the level of EQ-5D dimensions: evidence from England. Med Decis Making 2013, 33: 804–818. 10.1177/0272989X13482523CrossRefPubMed
Metadata
Title
The impact of preoperative patient characteristics on health states after total hip replacement and related satisfaction thresholds: a cohort study
Authors
Matthias Vogl
Rainer Wilkesmann
Christian Lausmann
Matthias Hunger
Werner Plötz
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Health and Quality of Life Outcomes / Issue 1/2014
Electronic ISSN: 1477-7525
DOI
https://doi.org/10.1186/s12955-014-0108-1

Other articles of this Issue 1/2014

Health and Quality of Life Outcomes 1/2014 Go to the issue

Research

Psychosocial factors as predictors of quality of life in chronic portuguese patients

Research

Cross cultural adaptation and validation of a Spanish version of the lower limb functional index

Research

Health related quality of life is differently associated with leisure-time physical activity intensities according to gender: a cross-sectional approach

Research

Development of a questionnaire specifically for patients with Ileal Orthotopic Neobladder (IONB)

Research

Latent variables may be useful in pain’s assessment

Research

Comparative efficacy of biologics as monotherapy and in combination with methotrexate on patient reported outcomes (PROs) in rheumatoid arthritis patients with an inadequate response to conventional DMARDs – a systematic review and network meta-analysis